Microba Life Sciences (MAP) Cash on Hand

MAP Cash on Hand in 2022: $21.68M

According to Microba Life Sciences latest financial reports the cash on hand of MAP is $21.68M, an increase of 4.78% to 2022. At the end of 2022 company had $20.69M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.

MAP Cash on Hand History from 2022 to 2023

MAP Cash on Hand by year

View the Top Cash on Hand Companies